Alzheimer’s disease is something many people have heard about, but it often feels distant until it affects someone close to home. With cases expected to rise in the coming decades, the federal government recently approved new funding aimed at improving research, treatment and support systems for those living with the disease. On Feb. 3, lawmakers passed the FY2026 Labor-Health and Human Services-Education Appropriations Bill, increasing federal investment in Alzheimer’s and related dementia research.
The bill adds $100 million in funding to Alzheimer’s research at the National Institutes of Health (NIH), raising the total yearly federal investment to about $3.9 billion. While researchers say this is a major step forward, it still falls slightly below the $3.98 billion the NIH recommended as the ideal amount needed to fully support national research goals.
Most of the new funding will go toward scientific research focused on understanding how Alzheimer’s develops and how it can be treated. The National Institute of Neurological Disorders and Stroke will receive the majority of the increase, while the National Institute on Aging will also receive additional funding. Together, these groups focus on studying the causes of Alzheimer’s, finding earlier ways to diagnose it and developing better treatment options.
One of the biggest goals of the new funding is helping scientists move discoveries from the laboratory into real treatments for patients. Researchers are looking beyond well-known proteins linked to Alzheimer’s and are searching for new targets that could lead to improved medications. Scientists are also testing combination treatments that use existing drugs alongside newer therapies. Another area of focus involves finding safe ways to deliver medicine directly into the brain, which has historically been difficult because of the brain’s natural protective barrier.
The bill also supports efforts to improve early diagnosis. Researchers are working to develop blood tests that could detect Alzheimer’s before symptoms appear. Early detection could allow doctors to begin treatment sooner and help patients plan for their future care. Scientists are also studying new ways to identify protein changes in the brain that current tests may miss, which could improve how the disease is diagnosed.
Another important part of the research focuses on understanding what causes Alzheimer’s in the first place. Scientists are studying how immune cells in the brain interact with neurons and whether these interactions help protect or harm brain function. Researchers are also exploring the connection between gut health and brain health, as well as trying to understand why some patients experience sudden episodes of cognitive decline.
The funding also supports studies focused on genetics and how Alzheimer’s affects different populations. Some researchers are examining rare gene variations that may naturally protect against the disease. Others are working to better understand how Alzheimer’s impacts people from different racial and ethnic backgrounds in order to improve prevention and treatment strategies.
In addition to research, the legislation focuses on improving care for patients and families. Funding will help evaluate programs such as the Guiding an Improved Dementia Experience, or GUIDE, model. This program aims to reduce stress for caregivers and help patients remain in their homes longer. Researchers are also studying possible connections between oral health and cognitive decline, which could lead to new prevention strategies.
The bill also invests in technology and data science. Scientists are using artificial intelligence and large health data sets to identify early behavioral signs of dementia. Lawmakers have also added new requirements for the NIH to report monthly to Congress about research grants to ensure funding is being tracked and used effectively.
Beyond research, the legislation provides $41.5 million to support the Building Our Largest Dementia Infrastructure for Alzheimer’s Act, known as BOLD. This program supports state, local and tribal health organizations that focus on early detection, reducing dementia risk, supporting caregivers and preventing avoidable hospital visits.
Lawmakers from both political parties supported the bill, emphasizing the growing need for Alzheimer’s research as the number of Americans living with the disease is expected to reach 12.7 million by 2050. While the impact of these investments will take time to fully appear, the funding represents an effort to better understand Alzheimer’s and improve support for families facing its challenges.
